An Atypical Femoral Fracture in a Patient on Long-term Alendronate Therapy

被引：0

作者：

Celbek, Gokhan ^{[1
]}

Ozsahin, Mustafa ^{[2
]}

Uslu, Mustafa ^{[3
]}

Onder, Elif ^{[1
]}

Kutlucan, Ali ^{[1
]}

Besir, Fahri Halit ^{[4
]}

Aydin, Yusuf ^{[1
]}

机构：

[1] Duzce Univ, Fac Med, Dept Internal Med, Duzce, Turkey

[2] Duzce Univ, Fac Med, Dept Phys Med & Rehabil, Duzce, Turkey

[3] Duzce Univ, Fac Med, Dept Orthopaed & Traumatol, Duzce, Turkey

[4] Duzce Univ, Fac Med, Dept Radiol, Duzce, Turkey

来源：

JOURNAL OF MUSCULOSKELETAL PAIN | 2014年 / 22卷 / 03期

关键词：

Alendronate; atypical femoral fracture; hip fractures; osteoporosis; osteoporotic fractures; SUPPRESSED BONE TURNOVER; POTENTIAL COMPLICATION; POSTMENOPAUSAL WOMEN; OSTEOPOROSIS; BISPHOSPHONATES; SHAFT;

D O I：

10.3109/10582452.2014.883031

中图分类号：

R49 [康复医学];

学科分类号：

100215 ;

摘要：

Background: Biphosphonates, especially alendronate, are used extensively and successfully for the treatment of osteoporosis. However, there are numerous recent studies that indicate low-energy subtrochanteric femoral fractures can be associated with long-term alendronate therapy. Findings: We present a 76-year-old female patient who has taken 70 mg alendronate per week for 7 years, and who presented with pain in the left thigh. Conclusions: The patient was diagnosed as atypical femoral fracture resulting from long-term alendronate use. The diagnosis and the treatment will be discussed with a review of the literature.

引用

页码：322 / 326

页数：5

共 50 条

[31] Discontinuation of alendronate and administration of bone-forming agents after surgical nailing may promote union of atypical femoral fractures in patients on long-term alendronate therapy
Lin T.-L.
Wang S.-J.
Fong Y.-C.
Hsu C.-J.
Hsu H.-C.
Tsai C.-H.
BMC Research Notes, 6 (1)
[32] Bilateral Atypical Femoral Fractures Due To A Long-Term Bisphosphonate Based Therapy
Jasqui-Romano, Salomon
Jasqui-Remba, Salomon
Jasqui-Bucay, Ariel
Jasqui-Bucay, Alan
JOURNAL OF BONE AND MINERAL RESEARCH, 2019, 34 : 136 - 137
[33] Sites of Femoral Fractures in the Fracture Intervention Trial (FIT) of Alendronate and Its Long-term Extension (FLEX).
Bauer, D. C.
Black, D. M.
Genant, H.
de Papp, A.
Santora, A.
Rosenberg, E.
Ensrud, K.
Cummings, S. R.
JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S340 - S341
[34] Subtrochanteric displaced insufficiency fracture after long-term alendronate therapy -: a case report
Sayed-Noor, Arkan S.
Sjoden, Goran O.
ACTA ORTHOPAEDICA, 2008, 79 (04) : 565 - 567
[35] ATYPICAL FEMORAL FRACTURE: THE PRICE FOR LONG TERM BISPHOSPHONATES ADHERENCE?
Oprea, E. -T.
Barbu, C. G.
Fica, S. V.
OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S752 - S753
[36] Long-term administration of alendronate sodium caused an atypical femoral shaft fracture in a 36-year-old woman: a case report and literature review
Duan, Wenyu
Qiang, Maochang
Zhang, Haidong
Zhou, Dongming
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2024, 52 (10)
[37] Sequential Subtrochanteric Femoral Fracture after Atypical Diaphyseal Fracture in a Long-Term Bisphosphonate User: A Case Report
Park, K. -T.
Lee, K. -B.
ACTA CHIRURGIAE ORTHOPAEDICAE ET TRAUMATOLOGIAE CECHOSLOVACA, 2015, 82 (02) : 157 - 160
[38] Long-term safety of bisphosphonates: atypical femoral fractures
Noguer-Martorell, M.
Pellicer-Jacomet, M. A.
Modamio, P.
Nadal Llover, M.
Lastra, C. F.
Guerrero-Guerrero, A.
Marino, E. L.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (05) : 967 - 968
[39] Patients' reasons for adhering to long-term alendronate therapy
Pepe, J.
Cipriani, C.
Cecchetti, V.
Ferrara, C.
Della Grotta, G.
Danese, V.
Colangelo, L.
Minisola, S.
OSTEOPOROSIS INTERNATIONAL, 2019, 30 (08) : 1627 - 1634
[40] Bilateral Atypical Femoral Fracture in a Bisphosphonate-Naïve Patient with Prior Long-Term Denosumab Therapy: A Case Report of the Management Strategy and a Literature Review
Auger, Kyle
Lee, Jason
Hong, Ian S.
Jankowski, Jaclyn M.
Liporace, Frank A.
Yoon, Richard S.
JOURNAL OF CLINICAL MEDICINE, 2024, 13 (10)

← 1 2 3 4 5 →